Comparative study of treatment results of different chemotherapy in patients with lymphoma cancer

Comparative study of the therapeutic results of Carboplatin, Etoposide, ARAC, Melfalan chemotherapy regimes with CCNU, Etoposide, ARAC, Melfalan diet as a diet before autologous stem cell transplantation in patients with resistant / recurrent lymphoma

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N70

Enrollment

Registered

2023-09-06

Start date

2023-07-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hodgkin lymphoma. Condition 2: Non Hodgkin lymphoma. Hodgkin lymphoma, unspecified Non-Hodgkin lymphoma, unspecified, unspecified site

Interventions

Intervention 1: First intervention group: First, the patient undergoes mobilization (stimulation of stem cells to move from the BM side to the peripheral blood by means of GCSF medicine). Then stem ce

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age above 18 years Having Hodgkin/non-Hodgkin of lymphoma resistant/relapsed Consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients who do not have suitable stem cells for transplantation during the initial stages of stem cell transplantation

Design outcomes

Primary

Measure	Time frame
Transplant complications. Timepoint: From the time of intervention every two weeks, then every one month, and then every two months until finally one year. Method of measurement: Observation.;Survival. Timepoint: Up to one year after transplantation. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Sadeghi

Esfahan University of Medical Sciences

sadeghi_hem@yahoo.com+98 31 3235 0218

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026